Robert G. Miller et al.: Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). In: The Cochrane library. 2012, doi:10.1002/14651858.cd001447.pub3, PMID 13129806.
Manoj Kumar Jaiswal: Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. In: Medicinal Research Reviews. Band39, Nr.2, März 2019, S.733–748, doi:10.1002/med.21528.
Yoshitaka Kawashima et al.: Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review. In: Neuropsychopharmacology reports. Band43, Nr.3, 2023, S.320–327, doi:10.1002/npr2.12364, PMID 37463744.
Manoj Kumar Jaiswal: Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. In: Medicinal Research Reviews. Band39, Nr.2, März 2019, S.733–748, doi:10.1002/med.21528.
Robert G. Miller et al.: Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). In: The Cochrane library. 2012, doi:10.1002/14651858.cd001447.pub3, PMID 13129806.
Yoshitaka Kawashima et al.: Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review. In: Neuropsychopharmacology reports. Band43, Nr.3, 2023, S.320–327, doi:10.1002/npr2.12364, PMID 37463744.